We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Crimson Tide Plc | LSE:TIDE | London | Ordinary Share | GB00BRJRV969 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 105.00 | 100.00 | 110.00 | 105.00 | 105.00 | 105.00 | 0.00 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Cmp Processing,data Prep Svc | 6.16M | -305k | -0.0464 | -22.63 | 6.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/1/2017 14:12 | Biggest daily trading volume in the last 4 weeks. | masurenguy | |
10/1/2017 14:12 | Is TIDE on the way to 4p+ | 338 | |
15/12/2016 12:32 | Good to hear from you Jamielein. The fact you've considered the investment case... and parted with your hard earned, gives me reassurance. Growth coupled with fantastic margins and a recurring revenue element drew my attention. The fact that they've concluded contracts with Nestle & other blue chips was the clincher. Kind regards GHF | glasshalfull | |
14/12/2016 20:02 | Ghf, good to see you here. It's been a while since we've had the same investment in common. I've been a lot less active recently due to a new job and fewer market opportunities in general. I've been holding TIDE for some time. I like the growth prospects which will hopefully make their current multiple look a lot more reasonable in the future. | jamielein | |
14/12/2016 17:55 | Courtesy to say I've been buying here over the last couple of months, although you wouldn't realise with the share price pull-back!!! Also delighted with today's update which sets TIDE up nicely for 2017. WH Ireland provide the following brief update on the back of today's t/s, "...positive update from TIDE this morning confirming not only that trading in the current year to 31 December is in line with expectations but also signalling that it has already absorbed some of the costs of a step change in investment to grow a much larger business in 2017 and beyond. For 2016, TIDE confirms revenue for the year is expected to total £1.8m (WHI £1.8m) whilst we look for a reported PBT of £0.4m, double the 2015 result. Staff count has also doubled in the past 18 months. One key takeaway from today's update is that the rollout of the major supermarket contract has been completed ahead of forecast hence revenues are now being recognised on the whole estate. Whilst this will clearly have some minor benefit in 2016, it means TIDE starts 2017 at full pelt underpinning future investment plans. This statement rounds off a hugely successful year for TIDE with three main contract wins/ extensions including a long-term tie up with the National Centre for Hereditary Disorders in Ireland (the first significant breakthrough into the Healthcare sector) and its largest ever multi-year contract signed with a UK supermarket in October. TIDE is utilising this momentum to step up investment in growing a much bigger business, the size and scope of which should become clearer in the New Year when we expect to revisit our 2017 and 2018 forecasts." --- Kind regards, GHF | glasshalfull | |
14/12/2016 13:50 | Going back to the pharmaceutical verification pilot, TIDE have many years of experience with scanning of bar codes on blood supplies, haemophilia patients in this country have been able to verify the safety of their medication via the mpro platform for years. I wonder if the work on the pilot was responsible for the additional functionality that has been added to the platform, as highlighted in the recent NCHCD contract. | billbyrne | |
14/12/2016 12:55 | I'm also happy to hold and will probably add. With their latest supermarket contract (their largest contract to date) now fully rolled out to nearly 500 stores, ahead of schedule, they will have a full years revenue in next years numbers. There is also an increased value contract extension with Interserve to add to that. They are also talking about international expansion, what I am looking for here is news on their pharmaceutical verification pilot. They are 5 months into the pilot now so hoping to hear about this in the not to distant. Sounds like it could be rolled out in several Asian countries if it goes ahead. Positive outlook as well. Barrie Whipp, Executive Chairman, commented "We have continued to win profitable, cash generative business with high levels of visible, recurring revenue from major organisations. These contracts provide a very stable platform from which to continue to grow the business but also excellent reference sites for attracting new customers, which is always a key challenge for smaller companies. Our team has doubled in number in 18 months and we expect our results to show a doubling of profits for the second year in a row. This gives us the resources and confidence for sound strategic investments which will enable us to drive the business forward aggressively in 2017 and beyond. The Board is very confident for the future" | billbyrne | |
14/12/2016 10:40 | Yes another good trading statement. The company is not cheap but is growing quickly. Happy to continue to hold. | jamielein | |
14/12/2016 10:18 | I am already in, enjoy the ride hopefully. | curlly | |
14/12/2016 10:10 | Another great trading statement today with a very positive outlook. This is well under the radar. Wake up peeps. | the shuffle man | |
02/12/2016 14:23 | And up she goes ! | the shuffle man | |
01/12/2016 15:58 | Looks like an overhang has been cleared. Hopefully the price will start moving up again. | the shuffle man | |
01/12/2016 15:45 | Hmmm what's going on here then. Huge buying all of a sudden. | flashheart | |
06/11/2016 17:27 | Agreed there are a lot of poor/dubious companies on Aim. However, it is my experience that if you pick a good one that is underpriced and meets some or all of my criteria, you can make money eg Eckoh, Tristel, Proactis, Airea and, I hope Crimson Tide | elbarracuda | |
02/11/2016 22:03 | Hi B-I You are right about AIM and share price movements. I am hoping that CT go the same way as Eckoh did - a steady stream of new long term contracts and contract renewals underpinning a 3/4 year steady rise in the share price. I am in for the long haul All the best with A & P - I have been burnt in the past and these days try to stick to Companies with no debt, good cashflow and good visibility of forward earnings | elbarracuda | |
30/10/2016 20:55 | Have just checked out Proxama & Ariana - both look high risk to me. I too will stick with t/o building, long contract winning and cashflow positive Crimson Tide | elbarracuda | |
22/10/2016 17:22 | I am with you Shuffle Man For me Crimson Tide is Eckoh mark II Spotted E at 5p and steadily built a good sized stake. Didn't start selling until the price went above 40P. Had to wait a few years, but really great opportunities only happen now and then. Tide has grown slowly, but surely. Each additional contract, signed on long contracts gives excellent visibility of forward earnings. Also a lot of the value of these contracts will go straight to the bottom line. Starting buying at around 1.8 and will continue to accumulate under 3.2 Now have a large stake, just under 0.75% - putting my money where my post is looking for a price of 12-15p in 3/4 years, if not before. Worked for me bigtime at Eckoh - barring some horrible unforeseen event hoping to repeat the trick here | elbarracuda | |
19/10/2016 09:33 | Forecasts are for Revenue to go from 1.4m in 2015 to 1.8m this year and to 2.5m in 2017. Profit to increase from 0.3m to 0.5m in 2016 and to 1m in 2017. I believe these look conservative after the recent deals that have been announced with more to come. As I said I am happy to hold as part of a portfolio. Will take a look at your other ones. | the shuffle man | |
19/10/2016 08:27 | I am finding a general lack of interest in many small cap stocks at the moment where it seems that investors who want to exit can only do when news is announced before volumes completely dry up again. Patience is required in these markets. Fundamentals will eventually come through in the valuation. Crimson seem to have made great strides over the last few years and I believe profits should now start to increase rapidly. Bap. Good luck in your investments. I am waiting patiently for an improved performance on a very strong outlook statement. | the shuffle man |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions